News

News
Partner news

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story
Partner news

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Partner news

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story
Partner news

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story
Partner news

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story
Partner news

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
JNJ Press releases

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

Read full story
Partner news

Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth

Read full story
Partner news

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story
JNJ Press releases

Johnson & Johnson Innovation to Join NXT Biomedical Therapeutic Device Incubator to Accelerate Medical Device Innovation

Read full story
Partner news

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Read full story
Partner news

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

Read full story
JNJ Press releases

Global Corporate Venturing Rising Stars Awards 2018: #8 Stacy Feld

Read full story